Adhoute X, Pénaranda G, Raoul JL, Bourlière M. Usefulness of the MESH score in a European hepatocellular carcinoma cohort. World J Hepatol 2017; 9(15): 711-714 [PMID: 28596819 DOI: 10.4254/wjh.v9.i15.711]
Corresponding Author of This Article
Dr. Xavier Adhoute, Department of Hepato-Gastroenterology, Hôpital Saint-Joseph, 26 Bd de Louvain Marseille, 13008 Paris, France. adhoute.xavier@neuf.fr
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letters To The Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/